The FDA is probing whether the Moderna vaccine can cause a rare side effect in teens : Coronavirus Updates : NPR

The FDA evaluation of Moderna’s software for an emergency use authorization of its coronavirus vaccine in adolescents will not be accomplished earlier than January, the corporate mentioned.

Angela Weiss/AFP through Getty Photographs

cover caption

toggle caption

Angela Weiss/AFP through Getty Photographs

The FDA evaluation of Moderna’s software for an emergency use authorization of its coronavirus vaccine in adolescents will not be accomplished earlier than January, the corporate mentioned.

Angela Weiss/AFP through Getty Photographs

The U.S. Meals and Drug Administration will want extra time to determine whether or not to approve Moderna’s COVID-19 vaccine to be used in kids ages 12 to 17, the corporate announced Sunday.

The prolonged timeline is so the FDA can look into experiences of a uncommon aspect impact — myocarditis, or the irritation of the guts muscle — in those that’ve gotten the shot. Moderna mentioned the FDA knowledgeable the corporate of the delay on Friday.

“The protection of vaccine recipients is of paramount significance to Moderna. The Firm is totally dedicated to working intently with the FDA to help their evaluation and is grateful to the FDA for his or her diligence,” Moderna mentioned in a press release.

The federal government’s evaluation of Moderna’s software for an emergency use authorization of its coronavirus vaccine in adolescents will not be accomplished earlier than January, the corporate mentioned. Moderna requested the FDA’s authorization to be used in adolescents in June.

The FDA is reviewing “current worldwide analyses” of the doable aspect impact, in response to Moderna.

A current unpublished research by Sweden’s Public Well being Company confirmed a barely elevated threat of irritation of the guts muscle and prompted 4 international locations to cease giving the shot to younger males and boys. The corporate’s vaccine had beforehand been approved by The European Medicines Company to be used in kids between ages 12 and 17.

Moderna mentioned it didn’t but have entry to the current worldwide analyses. The corporate estimated that greater than 1.5 million adolescents had obtained its vaccine and mentioned there did not look like an elevated threat of myocarditis in these youthful than 18.

Each the Fashionable and Pfizer-BioNTech COVID-19 vaccines have been proven to supply myocarditis as a uncommon aspect impact. Nevertheless, viral infections, together with COVID-19, can also trigger myocarditis. Most youngsters and adolescents who expertise myocarditis get better.

The FDA not too long ago authorized the usage of Pfizer-BioNTech’s COVID-19 vaccine in kids ages 5 to 11 on an emergency foundation. Specialists on the advisory panel mentioned the advantages of defending kids in opposition to COVID-19 outweigh the doable elevated threat of the uncommon aspect impact.

Moderna has already been granted emergency use authorization for its COVID-19 vaccine in adults.

The corporate mentioned Sunday that it could delay making use of for emergency authorization for its vaccine to be given to kids ages 6 to 11 till the FDA completes its present evaluation.